Evidence map›Paper›PMID 32158496›Full record

ArticleChinese medicine2020

Qishen granules exerts cardioprotective effects on rats with heart failure via regulating fatty acid and glucose metabolism.

Kuo Gao, Jian Zhang, Pengrong Gao, Qiyan Wang, Ying Liu, Junjie Liu, Yili Zhang, Yan Li, Hong Chang, Ping Ren and 3 more

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kuo Gao *1Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078 China.
Jian Zhang *2School of Life Science, Beijing University of Chinese Medicine, Beijing, 100029 China.
Pengrong Gao *2School of Life Science, Beijing University of Chinese Medicine, Beijing, 100029 China.
Qiyan Wang2School of Life Science, Beijing University of Chinese Medicine, Beijing, 100029 China.
Ying Liu2School of Life Science, Beijing University of Chinese Medicine, Beijing, 100029 China.
Junjie Liu3School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China.
Yili Zhang3School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China.
Yan Li1Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078 China.
Hong Chang4Traditional Chinese Medicine College, North China University of Science and Technology, Tangshan, 063210 Hebei China.
Ping Ren5School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029 China.
Jinmin Liu1Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078 China.
Yong Wang3School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China.ORCID 0000-0003-2841-5542
Wei Wang3School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China.
Beijing University of Chinese Medicine · CNNorth China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThe model of HF was induced by left anterior descending coronary artery ligation. Cardiac structure and function were assessed by cine magnetic resonance imaging (MRI) and echocardiography. Level of glucose metabolism was non-invasively evaluated by

resultsQSG ameliorated cardiac functions and attenuated myocardial remodeling in HF model. The levels of serum TC, TG and LDL-C were significantly reduced by QSG. The proteins mediating FA uptake, transportation into mitochondria and β-oxidation (FAT/CD36, CPT1A, ACADL, ACADM, ACAA2 and SCP2) as well as the upstreaming transcriptional regulators of FA metabolism (PPARα, RXRα, RXRβ and RXRγ) were up-regulated by QSG. As to glucose metabolism, QSG inhibited glycolytic activity by decreasing LDHA, while stimulated glucose oxidation by decreasing PDK4. Furthermore, QSG could facilitate tricarboxylic acid cycle, promote the transportation of ATP from mitochondria to cytoplasm and restore the mitochondrial function by increasing SUCLA2, CKMT2 and PGC-1α and decreasing UCP2 simultaneously.

conclusionQSG improved myocardial energy metabolism through increasing FA metabolism,inhibiting uncoupling of glycolysis from glucose oxidation.

Indexed as

Cardiac functionsFatty acid metabolismGlucose oxidationGlycolysisHeart failureMyocardial energy metabolism

Identifiers

PMID32158496
PMCPMC7055086
OpenAlexW3010652367

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.